• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

WW样结构域在TEL-PDGFβR转化中的正负调控作用。

Positive and negative regulatory roles of the WW-like domain in TEL-PDGFbetaR transformation.

作者信息

Chen Jing, Williams Ifor R, Kutok Jeffery L, Duclos Nicole, Anastasiadou Ema, Masters Shane C, Fu Haian, Gilliland D Gary

机构信息

Division of Hematology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.

出版信息

Blood. 2004 Jul 15;104(2):535-42. doi: 10.1182/blood-2004-01-0169. Epub 2004 Mar 30.

DOI:10.1182/blood-2004-01-0169
PMID:15054045
Abstract

TEL-platelet-derived growth factor-beta receptor (TEL-PDGFbetaR) is expressed in chronic myelomonocytic leukemias associated with t(5;12)(q33;p13), and the fusion tyrosine kinase retains a conserved WW-like domain in the PDGFbetaR autoinhibitory juxtamembrane region. Here we report that mutation of the 2 conserved tryptophan residues of the WW-like domain has opposing effects on TELPDGFbetaR kinase activation. Alanine substitution of W593, essential for protein-protein interaction in the context of other WW domains, impaired TEL-PDGFbetaR-mediated transformation of hematopoietic cells due to inhibition of TEL-PDGFbetaR kinase activity. In contrast, alanine substitution of W566, essential for structural integrity of WW domain in other contexts, had no effect on TEL-PDGFbetaR activation and oncogenic activity. Surprisingly, however, the W566A mutation suppressed the W593A phenotype. Double mutant W566A/W593A was indistinguishable from the wild-type fusion protein with regard to kinase activity, ability to confer factor-independent growth to Ba/F3 cells, or ability to induce a myeloproliferative disease in mice. Additional mutational analysis identified other substitutions within the WW-like domain in addition to W566A that could also suppress the W593A phenotype, including mutations predicted to diminish the autoinhibitory function of the juxtamembrane region. Therefore, the WW-like domain in the context of TELPDGFbetaR may have both positive and negative regulatory roles in kinase activation.

摘要

TEL-血小板衍生生长因子β受体(TEL-PDGFβR)在与t(5;12)(q33;p13)相关的慢性粒单核细胞白血病中表达,并且该融合酪氨酸激酶在PDGFβR自身抑制性近膜区域保留了一个保守的类WW结构域。在此我们报告,类WW结构域中2个保守色氨酸残基的突变对TEL-PDGFβR激酶激活具有相反的作用。W593的丙氨酸替代,在其他WW结构域的背景下对蛋白质-蛋白质相互作用至关重要,由于抑制了TEL-PDGFβR激酶活性,损害了TEL-PDGFβR介导的造血细胞转化。相比之下,W566的丙氨酸替代,在其他背景下对WW结构域的结构完整性至关重要,对TEL-PDGFβR激活和致癌活性没有影响。然而,令人惊讶的是,W566A突变抑制了W593A表型。双突变体W566A/W593A在激酶活性、赋予Ba/F3细胞因子非依赖性生长的能力或在小鼠中诱导骨髓增殖性疾病的能力方面与野生型融合蛋白没有区别。额外的突变分析确定了除W566A之外类WW结构域内的其他替代也可以抑制W593A表型,包括预测会减弱近膜区域自身抑制功能的突变。因此,TEL-PDGFβR背景下的类WW结构域在激酶激活中可能具有正向和负向调节作用。

相似文献

1
Positive and negative regulatory roles of the WW-like domain in TEL-PDGFbetaR transformation.WW样结构域在TEL-PDGFβR转化中的正负调控作用。
Blood. 2004 Jul 15;104(2):535-42. doi: 10.1182/blood-2004-01-0169. Epub 2004 Mar 30.
2
The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways.慢性粒单核细胞白血病中的TEL/PDGFβR融合蛋白通过STAT5依赖和非依赖途径发出信号。
Blood. 2001 Dec 1;98(12):3390-7. doi: 10.1182/blood.v98.12.3390.
3
H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22).H4(D10S170)是一种在乳头状甲状腺癌中经常发生重排的基因,在伴有t(5;10)(q33;q22)的非典型慢性髓性白血病中与血小板衍生生长因子受体β基因融合。
Blood. 2001 Jun 15;97(12):3910-8. doi: 10.1182/blood.v97.12.3910.
4
Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.由TEL/PDGFβR表达在小鼠中诱导产生的致命性骨髓增殖依赖于PDGFβR的酪氨酸579/581。
J Clin Invest. 2000 Feb;105(4):423-32. doi: 10.1172/JCI8902.
5
Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.Rabaptin-5是慢性粒单核细胞白血病中血小板衍生生长因子β受体的一种新型融合伴侣。
Blood. 2001 Oct 15;98(8):2518-25. doi: 10.1182/blood.v98.8.2518.
6
A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation.酪氨酸激酶的血小板衍生生长因子受体亚家族不同成员的类WW结构域中的单个氨基酸取代会导致受体组成性激活。
EMBO J. 1998 Dec 1;17(23):6912-23. doi: 10.1093/emboj/17.23.6912.
7
Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein.亨廷顿相互作用蛋白1/血小板衍生生长因子β受体融合蛋白的转化特性
J Biol Chem. 1999 Aug 6;274(32):22328-36. doi: 10.1074/jbc.274.32.22328.
8
Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin.小干扰RNA的稳定表达使TEL-PDGFβR对伊马替尼或雷帕霉素抑制作用敏感。
J Clin Invest. 2004 Jun;113(12):1784-91. doi: 10.1172/JCI20673.
9
The coupling of TEL/PDGFbetaR to distinct functional responses is modulated by the presence of cytokine: involvement of mitogen-activated protein kinases.细胞因子的存在可调节TEL/血小板衍生生长因子β受体与不同功能反应的偶联:丝裂原活化蛋白激酶的参与
Blood. 2003 Aug 15;102(4):1480-9. doi: 10.1182/blood-2002-09-2974. Epub 2003 Apr 24.
10
TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins.TEL/血小板衍生生长因子β受体融合蛋白激活信号转导和转录激活因子1及信号转导和转录激活因子5:酪氨酸激酶融合蛋白介导细胞转化的共同机制
Exp Hematol. 2000 May;28(5):584-93. doi: 10.1016/s0301-472x(00)00138-7.

引用本文的文献

1
Multiple allostery in the regulation of PDGFR beta kinase activities.血小板衍生生长因子受体β激酶活性调节中的多重变构现象
Acta Biochim Biophys Sin (Shanghai). 2024 Nov 29;57(3):344-355. doi: 10.3724/abbs.2024205.
2
Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia.截短型血小板衍生生长因子受体β(PDGFRB)的启动子置换驱动类费城染色体急性淋巴细胞白血病。
NPJ Precis Oncol. 2023 Dec 9;7(1):132. doi: 10.1038/s41698-023-00485-7.
3
Multiple - fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11).
一名患有t(5;17)(q32;q11)的骨髓增殖性肿瘤患者中的多种融合转录本
Mol Cytogenet. 2017 Feb 27;10:4. doi: 10.1186/s13039-017-0306-8. eCollection 2017.
4
Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis.通过通用定量逆转录聚合酶链反应分析,可方便地筛查不同的 PDGFRA 或 PDGFRB 融合基因。
Haematologica. 2010 May;95(5):738-44. doi: 10.3324/haematol.2009.016345. Epub 2010 Jan 27.
5
The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivo.小分子酪氨酸激酶抑制剂AMN107在体外和体内均能抑制TEL-PDGFRβ和FIP1L1-PDGFRα。
Blood. 2005 Nov 1;106(9):3206-13. doi: 10.1182/blood-2005-05-1932. Epub 2005 Jul 19.
6
Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformation.组成型激活的FGFR3突变体通过依赖和不依赖PLCγ的途径发出信号,以实现造血转化。
Blood. 2005 Jul 1;106(1):328-37. doi: 10.1182/blood-2004-09-3686. Epub 2005 Mar 22.
7
PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.PKC412可抑制锌指198-成纤维细胞生长因子受体1融合酪氨酸激酶,对干细胞性骨髓增殖性疾病治疗有效。
Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14479-84. doi: 10.1073/pnas.0404438101. Epub 2004 Sep 24.